Patent · US Active

Triazolinone compounds as HNE inhibitors

US9890169B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Elisabetta Armani · Parma, IT
Carmelida Capaldi · Parma, IT

Key dates

Filing date	Dec 12, 2016
Grant date	Feb 13, 2018
Priority date	—
Expiry date	Dec 12, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Triazolinone compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the therapy of diseases and conditions in which HNE is implicated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.